檢索結果 - David Whittaker
- Showing 1 - 2 results of 2
-
1
Potent and selective bivalent inhibitors of BET bromodomains 由 Michael J. Waring, Huawei Chen, Alfred A. Rabow, Graeme E. Walker, Romel Bobby, Scott Boiko, Rob H. Bradbury, Rowena Callis, Edwin Clark, Ian L. Dale, Danette L. Daniels, Austin Dulak, Liz Flavell, Geoffrey A. Holdgate, Thomas A. Jowitt, Alexey Kikhney, M. McAlister, Jacqui Méndez, D. Ogg, Joe Patel, Philip Petteruti, Graeme R. Robb, Matthew B. Robers, Sakina Saif, Natalie Stratton, Dmitri I. Svergun, Wenxian Wang, David Whittaker, David M. Wilson, Yi Yao
出版 2016Artigo -
2
Discovery of Pyrazolo[1,5-<i>a</i>]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors 由 William McCoull, Roman Abrams, Erica Anderson, Kevin Blades, Peter Barton, Matthew Box, Jonathan Burgess, Kate F. Byth, Qing Cao, Claudio Chuaqui, Rodrigo J. Carbajo, Tony Cheung, Erin Code, Andrew D. Ferguson, Shaun Fillery, Nathan O. Fuller, Eric T. Gangl, Ning Gao, Matthew Grist, David Hargreaves, Martin Howard, Jun Hu, Paul D. Kemmitt, Jennifer E. Nelson, Nichole O’Connell, D. Bryan Prince, Piotr Raubo, Philip B. Rawlins, Graeme R. Robb, Junjie Shi, Michael J. Waring, David Whittaker, Marta Wylot, Xiahui Zhu
出版 2017Artigo
相關主題
Biochemistry
Biology
Chemistry
Antibody
B cell
BCL6
BET inhibitor
BRD4
Binding site
Biophysics
Bivalent (engine)
Bromodomain
Cancer research
Cell culture
Computational biology
Drug discovery
Gene
Genetics
Germinal center
Histone
Immunology
In vitro
Lymphoma
Metal
Organic chemistry
Plasma protein binding
Potency
Small molecule